Biotech BioMarin Enters Into Exclusive Worldwide License Agreement With GC Biopharma and Hanmi Pharm for Investigational Next-Generation Enzyme Replacement Therapy, Adding a Second Potential Treatment for Fabry Disease October 30, 2026
Biotech Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast October 30, 2026
Biotech NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC’s Phase 3 Development at NEALS 2026 October 30, 2026
Biotech PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results October 29, 2026
Biotech Biohaven Reports Recent Business Developments and Third Quarter 2026 Financial Results October 29, 2026
Biotech Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit October 29, 2026
Search
Biotech
October 30, 2026
October 30, 2026
October 30, 2026
October 29, 2026
October 29, 2026
October 29, 2026
October 29, 2026
October 29, 2026
October 29, 2026
October 28, 2026
